Metabolic syndrome is increasingly common in urban India, yet most patients first hear about it after years of silent progression
Three biological drivers: chronic stress and cortisol, disrupted sleep and clock gene expression, and gut microbiota composition - explain why the condition develops and why lab values alone do not predict metabolic trajectory
Shift workers carry double the metabolic syndrome risk of day workers. But social jetlag, the mismatch between weekday and weekend sleep, carries a similar risk in people who consider their sleep normal
Multi-modal lifestyle intervention outperforms single-domain approaches in clinical trials
The five diagnostic criteria for metabolic syndrome: waist circumference, triglycerides, HDL, blood pressure, and fasting glucose, help with diagnosing the syndrome. They do not explain why two people with identical lab values and similar diets can have significantly different metabolic changes over five years. Genetics accounts for some of that divergence. The rest is driven by factors that rarely surface in a ten-minute OPD consultation: chronic stress, disrupted sleep, and gut microbiota composition. These are not lifestyle footnotes. Each has a documented mechanistic pathway to insulin resistance.
Cortisol acts at different points in the metabolic system simultaneously. It promotes central fat deposition, suppresses peripheral insulin sensitivity, and activates the sympathetic nervous system. Prolonged elevation also drives stress-induced behavioural changes including disrupted eating and physical inactivity, which adds to the damage through a second, parallel pathway. For IT professionals, healthcare workers, and shift workers in Indian metropolitan cities, populations under sustained deadline and performance pressure, this is not occasional stress. It is a chronic biochemical state with measurable metabolic consequences.
Shift workers carry roughly double the metabolic syndrome risk of day workers. But the risk is not confined to people who work nights. Among urban Indians who work standard hours, social jetlag, the mismatch between weekday and weekend sleep timing, disrupts clock gene expression, specifically BMAL1 and Per2. These genes regulate the circadian release of insulin. When their expression is disrupted, insulin secretion becomes arrhythmic, independent of what is eaten or how much. The metabolic consequence accumulates weekly, invisibly, in a population that considers itself to have normal sleep.
Siddha medicine prescribed circadian rhythm alignment as a metabolic intervention long before chronobiology had a name for it: dinner before sunset, sleep tied to natural light. Modern clinical trials are now producing data that validates what Siddha practitioners observed empirically.
Gut microbiota composition now qualifies as an independent modulator of metabolic health, not just a reflection of diet. Individuals with higher dietary diversity and microbiota index scores carry significantly reduced odds of metabolic syndrome. The pathway runs through the gut-liver axis: microbial metabolites, particularly short-chain fatty acids produced during fermentation of dietary fibre, influence hepatic insulin sensitivity directly. A gut microbiome depleted by low dietary diversity, ultra-processed food, and antibiotic overuse is one that is no longer protecting the liver from insulin resistance.
Most patients diagnosed with metabolic syndrome are counselled about cardiovascular risk. The oncological connection rarely comes up in those conversations, when it should.
Chronic hyperinsulinaemia (sustained elevated insulin), to compensate insulin resistance, drives IGF-1 (insulin-like growth factor 1) signalling. IGF-1 promotes cellular proliferation. Combined with the low-grade systemic inflammation generated by visceral adipose tissue, the internal environment of metabolic syndrome is one that supports tumour development and progression. Elevated risk has been documented for colorectal, endometrial, liver, breast, and pancreatic cancers.
This is not grounds for alarm. It is grounds for action. Every lifestyle intervention that reduces visceral fat and improves insulin sensitivity lowers both cardiovascular and oncological risk through the same biochemical pathways.
The most clinically important fact about metabolic syndrome is also the most consistently underemphasised at the point of diagnosis: it is largely driven by lifestyle, and it responds to lifestyle intervention.
Metabolic Syndrome is largely driven by poor lifestyle choices, physical inactivity, excess calorie intake, and poor sleep. With consistent lifestyle changes, a significant proportion of patients can reverse or improve their metabolic profile. However, in some individuals, especially those with strong genetic predisposition or advanced disease, lifestyle alone may not be sufficient and medications become necessary.
Dr. Supreeth Chandrashekar, DM Endocrinology, MRCP (UK), Consultant at Apollo Sugar Clinics, Bengaluru
Nutrition, physical activity, stress management, sleep quality, social connection, and reduction of harmful substances can be considered as the six pillars of the evidence-based lifestyle management. It is important to understand that these are not interchangeable. Correcting only the nutrition does not compensate for chronic sleep deprivation. Similarly, structured exercise does not offset the metabolic cost of sustained stress. Each one of these operates through a partially independent pathway, which is why addressing one or two pillars while neglecting the others tends to produce partial and temporary results.
When it comes to nutrition, traditional Indian dietary patterns, diverse legumes, fermented preparations, seasonal vegetables, and minimally processed grains, align more closely with metabolic health than either the ultra-processed urban diet or restrictive elimination protocols. This prescription is not a recent discovery. It is a return to food patterns that existed before industrial processing made them convenient rather than healthy.
Non-exercise activity thermogenesis (NEAT), refers to the energy expended through daily movement outside formal exercise such as walking between appointments, household activity, standing rather than sitting. For most Indian urban patients, this is the metabolic variable that shifts most easily and has the most underappreciated impact. Thirty minutes of exercise does not compensate for the eight hours at a desk. Consistent movements throughout the day contributes independently to insulin sensitivity in ways that a single gym session cannot produce.
Yoga and pranayama have documented effects on cortisol regulation and autonomic function in controlled studies. This is not a concession to alternative medicine. It is peer-reviewed physiology.
Dr. Senthil Nathan translates the lifestyle-first principle into a structured clinical protocol. For early-stage patients with central obesity, borderline triglycerides, and no major comorbidities, the first prescription contains no medicines.
His first prescription is a 30-day protocol: dinner before sunset, consistent sleep-wake timing, seven to eight hours of sleep nightly, daily pranayama and mind-body practice, and a minimum of 45 minutes of physical activity calibrated to the patient's constitution. At one month, he reassesses fasting blood sugar, HbA1c, and lipid profile. If there is good improvement, the patient continues the same lifestyle as their primary medicine. No drugs are needed. Siddha medicines, selected on the basis of naadi pulse diagnosis and Mukkutram humoral assessment, are introduced only when biomarkers fail to respond.
The boundary conditions matter. Siddha medicine works best in metabolic syndrome when the condition is in the early stage and there are no major comorbidities. If the patient does not have kidney failure, liver damage, or heart disease, reversal through Siddha-guided lifestyle modification is achievable.
“We first restore the body's natural healing capacity through food, routine, and lifestyle. Medicines are added only when the body needs additional support" explains Dr. Senthil Nathan Krishnamoorthy, Senior Siddha Medical Officer, Government of Tamil Nadu.
When pharmacotherapy is indicated, whether due to established comorbidities, strong genetic predisposition, or biomarkers that do not respond to lifestyle modification, first-line agents include metformin for glucose dysregulation, statins for dyslipidaemia, and antihypertensives as appropriate. In these patients, medication and lifestyle work together. Neither replaces the other.
The infrastructure for metabolic syndrome screening exists on paper. The NPCDCS (National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke) provides a framework for population-level screening, and FSSAI food labelling reforms are beginning to improve nutritional transparency in packaged foods. The implementation gap between policy and practice, however, remains substantial.
"In a typical OPD day I see around 25 to 30 patients with diabetes and another 5 to 10 without diabetes. Among them, nearly 80 percent are unaware that they already have a metabolically unhealthy profile or meet criteria for Metabolic Syndrome", notes Dr. Supreeth Chandrashekar, DM Endocrinology, MRCP(UK), Consultant, Apollo Sugar Clinics, Bengaluru
The problem runs deeper than infrastructure.
“About 90 percent of the public are still not ready to change food style and physical activity. They expect medicines alone to fix it. This mindset is the biggest barrier. We give extreme importance to education, good jobs, and good income. But we give zero importance to food, exercise, sleep, and mental peace. People are losing their age, their life, and their future, all at once. And the bitter truth is: they know it. Yet they live with a false hope that I'll deal with it later”, expresses Dr. Senthil Nathan Krishnamoorthy, Senior Siddha Medical Officer, Government of Tamil Nadu.
That deferred action, delayed until organ damage is already underway, is precisely what metabolic syndrome depends on. The science, screening tools and the interventions exists. What is missing is not knowledge. It is the decision to act before the damage ruins our daily functioning.
Chest pain or tightness
Sudden severe headache
Sudden vision changes
Blood pressure above 180/110 mmHg
Fasting glucose above 300 mg/dL
Unexplained rapid weight gain with breathlessness.
Go to the nearest emergency department without delay.
Safety disclaimer: Patients with type 2 diabetes on medication, chronic kidney disease, cardiovascular disease, or those who are pregnant should not modify diet, exercise, or supplementation without consulting their treating physician.
Siddha medicines should be taken only under the guidance of a qualified doctor and along with proper dietary restrictions. Self-medication can be harmful. Treatment is individualised. Patients must inform their allopathic doctor about all herbs, supplements, and Siddha therapies, and their Siddha physician about all allopathic medicines, particularly anti-diabetics, anti-hypertensives, and blood thinners.
For many patients, particularly those diagnosed before major organ damage has set in, consistent lifestyle changes can bring all five metabolic criteria back within normal range. How far that improvement goes depends on genetics, family history, and how long the condition has been progressing. Some patients achieve full normalisation through lifestyle alone. Others need pharmacotherapy alongside it. What the evidence does not support is the idea that metabolic syndrome is a one-way road.
Not always, and not initially. Both experts in this series use lifestyle intervention as the primary approach in early-stage metabolic syndrome without major comorbidities. Medication is considered when biomarkers fail to respond, genetic predisposition is strong, or organ damage is already present.
Sleep quality and timing directly affect insulin sensitivity, cortisol regulation, and clock gene expression. Shift workers carry double the metabolic syndrome risk of day workers. Seven to eight hours of consistent, well-timed sleep is not optional. It is a clinical requirement for metabolic recovery.
Only under qualified medical supervision. Certain Siddha preparations can interact with anti-diabetics, anti-hypertensives, and blood thinners. Patients must disclose all Siddha treatments to their allopathic doctor and all allopathic medications to their Siddha physician before proceeding.
Based on Dr. Senthil Nathan's clinical protocol: dinner before sunset, consistent sleep-wake times, 7 to 8 hours of quality sleep, daily pranayama and stress management practices, and 45 minutes of physical activity daily. Biomarkers including fasting glucose, HbA1c, and lipid profile are reassessed after one month before deciding whether additional intervention is needed.
References:
Consultation, W. H. O. (2025). Burden, determinants and treatment status of metabolic syndrome among older adults in India https://pubmed.ncbi.nlm.nih.gov/40017860/
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009). Harmonizing the metabolic syndrome. Circulation, 120(16), 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Jones, B. (2024). Impact of stress hormones on metabolic syndrome development and management. Endocrinology and Metabolic Syndrome, 13, 436. https://www.longdom.org/open-access/impact-of-stress-hormones-on-metabolic-syndrome-development-and-management-1101932.html
Sooriyaarachchi, P., Jayawardena, R., Pavey, T., & King, N. A. (2022). Shift work and the risk for metabolic syndrome among healthcare workers: A systematic review and meta-analysis. Obesity Reviews, 23(10), e13489. https://doi.org/10.1111/obr.13489
Yan, J., Wang, Z., Bao, G., Xue, C., Zheng, W., Fu, R., Zhang, M., Ding, J., Yang, F., & Sun, B. (2024). Causal effect between gut microbiota and metabolic syndrome in European population: A bidirectional Mendelian randomization study. Cell and Bioscience, 14, 67. https://doi.org/10.1186/s13578-024-01232-6
Chan, B. S., Yu, D. S. F., Wong, C. W. Y., & Li, P. W. C. (2025). Multi-modal interventions outperform nutritional or exercise interventions alone in reversing metabolic syndrome: A systematic review and network meta-analysis. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwaf167
Teede, H. J., Lim, S. S., Norman, R. J., Joham, A. E., Moran, L. J., Dokras, A., & Billett, M. (2023). Six pillars of lifestyle medicine. Lifestyle Medicine, 4(1), e80. https://doi.org/10.1002/lim2.80
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., & Vijay, V. (2006). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia, 49(2), 289–297. https://doi.org/10.1007/s00125-005-0097-z
MSM
